指南临床适用性评价工具(2.0版)解读  

Interpretation of the instrument for evaluating clinical applicability of guidelines(version 2.0)

作　　者：刁莎 李思雨 石雨晴[1,2,3,4,6] 刘峥 康德英 刘关键[7] 赵荣生[8] 曾力楠[1,2,3,4] 易秋莎[1,2,3,4] 李海龙[1,2,3,4] 黄超[9] 王强 张伶俐 DIAO Sha;LI Siyu;SHI Yuqing;LIU Zheng;KANG Deying;LIU Guanjian;ZHAO Rongsheng;ZENG Linan;YI Qiusha;LI Hailong;HUANG Chao;WANG Qiang;ZHANG Lingli(Department of Pharmacy,West China Second University Hospital,Sichuan University,Chengdu 610041,P.R.China;Evidence-based Pharmacy Center,West China Second University Hospital,Sichuan University,Chengdu 610041,P.R.China;NMPA Key Laboratory for Technical Research on Drug Products in vitro and in vivo Correlation,Chengdu 610041,P.R.China;Key Laboratory of Birth Defects and Related Diseases of Women and Children,Ministry of Education,Chengdu 610041,P.R.China;West China School of Medicine,Sichuan University,Chengdu 610041,P.R.China;West China School of Pharmacy,Sichuan University,Chengdu 610041,P.R.China;Chinese Evidence-based Medicine Center,West China Hospital,Sichuan University,Chengdu 610041,P.R.China;Department of Pharmacy,Peking University Third Hospital,Beijing 100191,P.R.China;Medical Management Service Guidance Center,National Health Commission of the People’s Republic of China,Beijing 100044,P.R.China)

机构地区：[1]四川大学华西第二医院药学部,成都610041 [2]四川大学华西第二医院循证药学中心,成都610041 [3]国家药品监督管理局药物制剂体内外相关性技术研究重点实验室,成都610041 [4]出生缺陷与相关妇儿疾病教育部重点实验室,成都610041 [5]四川大学华西临床医学院,成都610041 [6]四川大学药学院,成都610041 [7]四川大学华西医院中国循证医学中心,成都610041 [8]北京大学第三医院药剂科,北京100191 [9]国家卫生健康委医疗管理服务指导中心,北京100044

出　　处：《中国循证医学杂志》2023年第11期1318-1322,共5页Chinese Journal of Evidence-based Medicine

基　　金：国家卫健委医管中心委托项目(医管中心标准管理处[2020]054号)。

摘　　要：指南临床适用性评价工具(2.0版)旨在定量评估临床实践指南的临床适用性,并为改善其临床适用性提供建议。该工具由指南目标使用者担任评价者,包括评价者基本信息、评价条目、评分方案共3个部分,其中评价条目部分涵盖领域可获得性、可读性、可接受性、可行性和总体评价。本文对该工具的适用范围、使用说明、条目等内容进行详细解读,以便使用者更好地理解和使用。The instrument for evaluating clinical applicability of guidelines(version 2.0)is designed to evaluate the clinical applicability of guidelines quantitatively.It is helpful to select guidelines with high clinical applicability and provide suggestions for revision.The evaluators are consistent with the target users of guidelines.The instrument consists of basic information,evaluation items and scoring scheme.The evaluation items are related to accessibility,readability,acceptability,feasibility and overall evaluation.Therefore,this article provides a detailed interpretation of the instrument and references for future users.

关 键 词：指南 临床适用性 评价工具(2.0版) 解读 

分 类 号：R-3[医药卫生]